tirzepatide phase 2

tirzepatide phase 2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type diabetes (SURPASS-3): a randomised, open-label, parallel-group, 3 trial Efficacy and Safety of Tirzepatide

Name: tirzepatide phase 2 Once-weekly versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type diabetes (SURPASS-3): a randomised, open-label, parallel-group, 3 trial Efficacy and Safety of Tirzepatide
Brand: 2m-capital.com
SKU: 15096264232
Price: 23.44 USD
Availability: InStock
Rating: 4.3249 (10 reviews)

SKU: 15096264232

4.3

EUR23.44 EUR71.44

Pay in 4 interest-free payments of $5.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

Description

Heres whats driving the surge

E.UferC.KuhnH.BorchertA

CrossRef Reshaping the Future of MASLD - From Pathophysiological Mechanisms to New Therapeutic Horizons Dimitrios Patoulias, Manfredi Rizzo Current Pharmaceutical Design .2026